BioUtah president & CEO Kelvyn Cullimore interviews Mayer Brown’s George O’Brien to legal issues life sciences companies face when dealing with the FDA. Topics discussed include:
- Utah’s emergence as a national and global player in the life sciences industry
- Life sciences regulatory legal issues
- Updates at the FDA
- Negotiating with the FDA during the review process
- Much more
